Reports on RUNX2 and WWOX protein expression in ES are sparse and heterogeneous, and inconsistent findings may stem from unique molecular features of ES, differences in tumor microenvironment, methodological variability, or tumor heterogeneity. This evidence concerns the gene RUNX2 and neoplasm.